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Abstract. We present the development of COMMODITY12, a Personal Health System (PHS) to assist in the provi-
sion of continuous and personalised health services to diabetic patients, thus empowering their lifestyle regardless
of their location. COMMODITY12 consists of ambient, wearable and portable devices, which acquire, monitor and
communicate physiological parameters and other health-related context of an individual, such as physical activity
and vital body signals. This data is interpreted by intelligent agents that use expert biomedical knowledge to derive
important insights about the individual’s health status, which are then presented in the form of active feedback to
the patient directly from the device, or via health professionals who assist in diagnosis, treatment and life man-
agement. The emphasis of the work is on the design of the PHS in terms of its main components, their integration
and deployment to address major problems of interest to both diabetic patients and doctors that treat diabetes.
Keywords: personal health systems, agent technology, diabetes management, interoperability.
1. Introduction
Diabetes mellitus, or simply diabetes, is a group
of metabolic diseases in which a person has high
blood-sugar, either due to the pancreas failing to
produce enough insulin, or because cells do not re-
spond to insulin as expected [2]. Diabetes mani-
fests itself in three types:
*Corresponding author. E-mail: ozgur.kafali@rhul.ac.uk
– Type 1, also referred to as insulin-dependent
diabetes, is characterised by the loss of insulin-
producing cells in the pancreas which leads
to insulin deficiency. It affects 10% of the di-
abetics in Europe and the US. It can affect
both adults and children.
– Type 2, also known as non-insulin-dependent
diabetes, is caused by insulin resistance, a
condition in which cells fail to use insulin
properly. Type 2 diabetes is due primarily
to lifestyle factors, such as obesity, diet, and
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sedentary lifestyle, and to a certain extent oc-
curs as a result of genetics. It is the most com-
mon type of diabetes, affecting 90% to 95%
of diabetics.
– Gestational diabetes, a type of diabetes that
temporarily affects some otherwise healthy
pregnant women. It occurs in about 2% to 5%
of all pregnancies and typically disappears af-
ter the delivery of the baby. Despite disap-
pearing once the pregnancy is over, it leaves
women with a higher risk of later developing
type 2 diabetes.
All forms of diabetes increase the risk of short-
term complications such as hypoglycemia and hy-
perglycemia (very low and high blood glucose,
respectively), both of which are life-threatening.
Longer-term complications include how diabetes
affects the eyes (retinopathy), heart (cardiovas-
cular disease), kidneys (nephropathy), and nerves
and feet (neuropathy).
The management of diabetes is becoming an
increasingly important problem worldwide. In
2000, according to the World Health Organisa-
tion, at least 171 million people (or 2.8% of the
whole population) suffered from diabetes. The Na-
tional Health and Nutrition Examination Survey
(NHANES III) in the US demonstrated that, in
the population over 65 years old, up to 20% have
diabetes, with 40% having either diabetes or its
precursor form of impaired glucose tolerance. The
likelihood of being diagnosed with diabetes in-
creases with age, and the numbers of older persons
with diabetes are expected to grow as the elderly
population increases in number. It is estimated
that by 2030, the number of people suffering from
the disease will almost double.
The aim of this work is to present a Personal
Health System (PHS), which we will refer to as
COMMODITY12
1, seeking to support the man-
agement of diabetes. It has been shown that a large
portion of the time spent by diabetic patients is
devoted to management of self-measured data [51].
The problem here is that despite having a chronic
illness, diabetic patients are not able to take a
number of crucial decisions related to their treat-
ment, and they need to consult healthcare profes-
1COMMODITY12 stands for COntinuous Multi-
parametric and Multi-layered analysis Of DIabetes TYpe
1 & 2.
sionals (such as general practitioners, dietitians,
ophthalmologists, chiropodists, pharmacists, spe-
cialists and nurses). Thus, one of the main con-
cerns of COMMODITY12 is to advise diabetic pa-
tients by providing them with recommendations
and alerts based on their data, and to assist med-
ical personnel who are in charge of these patients
with taking informed and timely decisions. The fo-
cus of the work is on diabetes types 1 and 2 in gen-
eral and on the interaction of these diabetes types
with cardiovascular co-morbidities in particular.
We have selected diabetes types 1 and 2 as these
two types are chronic conditions that cannot be
cured. Type 1 treatment is possible with external
supply of insulin and its analogues. Insulin is an in-
jectable drug, and is self-administered by patients
using insulin pens. Some patients use continuous
insulin injections with miniaturised insulin pumps.
Similarly, type 2 diabetes can be controlled with
medications. Currently these are mostly oral med-
ications with the addition of some new injectable
ones. Their activity is based on increased insulin
secretion or sensitisation of the cells toward insulin
activity. The important issue here is that all types
of diabetes medication share the risk of adverse
effects, of which the most serious is hypoglycemia.
It is necessary to react to this life-threatening con-
dition immediately, with either drugs or food in-
take.
The normalisation of the blood-glucose level is
one of the parameters that must be monitored
and interpreted by a PHS according to a formal
model of the disease. Monitoring in our approach
means that the system consists of ambient and/or
body (wearable and portable) devices, which col-
lect, aggregate and communicate physiological pa-
rameters (e.g. blood glucose) and other health-
related context of an individual, such as activity
and vital body signals. Our approach also encom-
passes interpretation of these parameters and sig-
nals by intelligent agents that use expert biomed-
ical knowledge of the disease to derive important
cause-effect relations about the individual’s health
status. These relations are then presented in the
form of active feedback to the patient directly from
the device, or via healthcare professionals who as-
sist in diagnosis, treatment and life management.
Our work provides a general agent reasoning
framework to draw conclusions from observations.
The framework separates domain-specific knowl-
edge (e.g. how to respond to measurement of blood
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Fig. 1. General architecture of COMMODITY12.
glucose) from generic functionality (e.g. diagno-
sis support) that is reusable in different environ-
ments. Also, as different technologies are used in
healthcare, our system uses interoperability stan-
dards and supports adding new sources of infor-
mation. To exemplify our work, implementation
details are provided wherever necessary, and our
system is tested on two important scenarios of di-
abetes. The specific contributions of our work are:
– We propose a general distributed framework
to be used as a PHS for management of dia-
betes, based on interoperability standards in
healthcare informatics.
– We present the body area network of the
framework that utilises commercially avail-
able sensors to monitor diabetic patients.
– We propose an agent architecture that is
founded on model-based diagnosis and sup-
ports temporal reasoning about patient ob-
servations, utilising formalised medical knowl-
edge, and is able to interact with its environ-
ment to communicate results.
– We provide an implementation of the frame-
work, and demonstrate its workings on two
important problems related to diabetes.
The rest of this paper is structured as follows.
Section 2 introduces the COMMODITY12 frame-
work and describes its components. Section 3 in-
troduces the LAMA agent architecture and ex-
plains its most important characteristics. Section
4 reviews our design choices, introduces the agent
platform GOLEM used for the deployment of our
system, including the details of how interoperabil-
ity of components is achieved. Section 5 presents
our case study for two different scenarios on dia-
betes monitoring and diagnosis as well as demon-
strating different parts of our PHS. Section 6 re-
views relevant literature and compares it with our
work. Section 7 summarises our approach and out-
lines our plans for future work.
2. Diabetes Management Framework
To introduce COMMODITY12 we first present
the general architecture of the system and we
briefly describe its main components. We then
concentrate on the description of three key com-
ponents: the commercially available sensors cus-
tomised for diabetes, the agent-based reasoning
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Fig. 2. Sequence diagram for monitoring of a patient.
component, and the infrastructure that enables
the interaction among various components in a re-
liable way.
2.1. PHS Architecture
Fig. 1 depicts our proposed architecture for a
smart healthcare environment. It consists of three
main components which are connected via the me-
diator middleware: (i) a smart hub enabling input
to be taken directly from the patient, (ii) a system
of web services for healthcare personnel, and (iii)
a multi-agent system of personal agents associated
with patients and medical personnel in order to
provide them with advice, alerts and diagnoses.
The smart hub interfaces with the patients in
two ways: via the sensors of a body area network
(BAN) and via a user interface (UI) on a mobile
telecommunication device such as a smart phone
or a tablet PC. The web services act as a set of
UIs for medical personnel to record observations,
and other treatment-related data about the pa-
tients. In addition, they provide connectivity with
other components of the system through the me-
diator. The database stores data relevant to the
healthcare process for all patients in the system.
The personal agents within the multi-agent sys-
tem are responsible for reasoning based on the ob-
servations retrieved from the environment. They
make use of logic-based rules that have been for-
malised out of the medical guidelines selected by
the doctors and other domain-specific knowledge
related to diabetes.
The components of the framework are connected
through the mediator, a middleware for interop-
erability standards in healthcare informatics. The
framework and the architecture will be exempli-
fied by presenting two typical use cases. The first
case-study involves a patient monitoring his blood-
glucose level using the system (see Section 5.1), as
shown in the sequence diagram of Fig. 2. The sec-
ond case-study is concerned with the examination
of a patient’s diabetic foot by a doctor (see Section
5.2), as shown in the sequence diagram of Fig. 3.
The details of how data flows through the middle-
ware (e.g., translations between components) will
be described in Section 2.4.
2.2. Sensors for Diabetes Monitoring
We utilise various types of sensors in our PHS,
which can be divided into different categories
based on their suitability for inclusion in the
present smart hub. The sensors are depicted in Ta-
ble 1 and described below, with the objective of
seeing whether they meet the requirements for our
purpose.
The following wireless sensors are available on
the market, and are already capable of connecting
to the smart hub:
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– Glucose monitoring by finger prick (GlucoTel
sensor2, Table 1a).
– Blood pressure monitoring, non-continuous
(PressureTel sensor2, Table 1b).
– Body weight monitoring (WeightTel sensor2,
Table 1c).
None of the above sensors is expected to be consid-
ered obtrusive by the patients. In addition to these
sensors, we consider adding the following sensors
to the smart hub, all of which are acceptable for
the patient to wear during the day/night:
– Respiratory effort monitoring (thoracic band
tension sensor3, Table 1d). This sensor is of
a similar size and weight to widely popular
sports heart rate monitors.
– Activity monitoring (tri-axial accelerome-
ter3, Table 1e). This sensor is planned to be
mounted on the chest band of the respira-
tory effort sensor. Also, additional mount-
ing points are possible in order to gather al-
ternative information about the patient’s ac-
tivity. Activity monitoring will be done in
a multi-parametric fashion including; funda-
mental signal pre-processing, artefact detec-
tion, feature extraction and inactivity detec-
tion for data rate reduction to be done at ei-
ther the sensors of the smart phone applica-
tion. Further interpretation will be done at
later stages of the system in combination with
2http://www.bodytel.com
3http://www.biopac.com
other activity-related contextual data (such
as smart phone accelerometer activity and
user input) where the agents will work to-
wards diagnosis assistance. In the remit of ac-
celerometer signals interpretation one avenue
to be explored is energy expenditure estima-
tion where [39] represents a strong starting
point.
– 3-channel ECG (available soon from BodyTel
in collaboration with IEM4, Table 1f). The
main advantage of this sensor is its similarity
to Holter monitors, which are commonly used
for ambulatory cardiovascular monitoring.
The first two sensors described above require elec-
tronic signal conditioning and processing as well
as wireless capability to be added. We consider do-
ing this using low-power MPS430 micro controllers
[62] and the SimpliciTI [61] wireless protocol by
Texas Instruments, in combination with the low-
power nRF24LE1 Nordic Transceiver [44].
Moreover, the following sensor is considered for
clinical trials, but not included in the BAN:
– Continuous glucose monitor (CGM5, Table
1g). A possible application of this sensor is to
educate patients on the fluctuations of blood
glucose levels in their body. This sensor is to
be partially implanted on the side of the ab-
domen and to be worn for 3 to 5 days con-
4http://www.iem.de/beam
5http://www.medtronicdiabetes.com/products/
guardiancgm
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a) b) c)
d) e) f)
g)
Table 1
Sensors (a, b, c, and f by BodyTel, d and e by BioPac,
g by MedTronic): a) GlucoTel sensor. b) PressureTel sen-
sor. c) WeightTel sensor. d) Thoracic band tension sensor.
e) Tri-axial accelerometer. f) 3-channel ECG. g) Guardian
continuous glucose monitor.
tinuously; hence, it is expected that some ini-
tial reticence and potential discomfort will be
incurred to the patient.
The sensors described above offer great poten-
tial for intelligent data acquisition based on real-
time data streams. Given their properties as de-
scribed above, they are considered suitable for
monitoring patients with Type 1 and Type 2 dia-
betes, and to be utilised in our PHS.
2.3. Personal Agents and their Deployment
The COMMODITY12 PHS uses personal agents
as active software components to (a) manage the
specific characteristics of individuals in user pro-
files, (b) become aware of contextual conditions
about the domain by observing the environment
through sensors, and (c) process intelligently in-
formation from observations by reasoning logically
with them to support monitoring, the provision of
alerts, advice, and more sophisticated tasks such
as diagnosis. Intelligent processing here is con-
strued as the ability of the agent to operate with
the complexity that arises from the environment
and the ability of the agent to take action in the
presence of incomplete information.
Our work proposes the LAMA (Logic Agents
for Medical Advice) agent architecture, which will
be used to build COMMODITY12 agents in gen-
eral and develop their reasoning capabilities in
particular. The reasoning capabilities will allow a
personal agent identify time-critical observations
and react to them without ignoring goals and plans
the agent has developed during the interaction
with the patient or the relevant medical personnel.
To deploy multiple LAMA agents we use the
agent platform GOLEM [13,14]. This platform has
been selected because it has been developed specif-
ically for the deployment of logic-based agents,
like LAMA, and has been used successfully in a
number of applications [63,15,16,12,42]. GOLEM
also supports inter-agent communication over a
network and the deployment of objects (entities
that are not agents) as well as mechanisms of
interaction between agents and objects. More-
over, GOLEM uses the notion of container to de-
ploy agents on different machines over a network,
thus giving the possibility to develop complex dis-
tributed applications. Next, we focus on the in-
frastructure of our framework. More details on
LAMA will be given in Section 3.
2.4. The Mediator
One of the main issues with systems devel-
oped from different and heterogeneous compo-
nents is how to handle component interoperability.
In COMMODITY12 interoperation of this kind is
particularly important as the GOLEM platform
uses first-order logic terms to represent informa-
tion while sensors and web-service do not. There-
fore we need to transform data such as physiologi-
cal values coming from sensors or patient informa-
tion coming from the medical database into logical
terms accepted by GOLEM and vice-versa.
The integration problem in medical systems is
well documented, for example see [10]. Hetero-
geneity has many consequences on the develop-
ment of interoperable systems and has driven the
community to develop a new kind of software tech-
nology: the Enterprise Service Bus (ESB). Instead
of developing countless adapters to bridge the dif-
ferences in terms of formats and protocols, the
ESB approach provides a complete centralised and
streamlined message transformation framework.
The responsibility of interpreting the data is thus
shifted towards the ESB and is done in a single
place.
To support the COMMODITY12 mediator, we
employ Mirth Connect (MC) 6, an ESB interop-
6http://www.mirthcorp.com/products/mirth-connect
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erable communication framework between health-
care systems that supports a wide range of data
standards and communication protocols, such as
HL7 v2/v3, DICOM, HTTP, MLLP, databases
and web services. Communication in MC is or-
ganised in channels. Data is channelled from one
side of the pipe; it is then filtered, transformed
and then dispatched towards its final destination.
Each channel receives data through one single end-
point, called the source connector. This connec-
tor accepts requests (or creates requests) from (to)
external systems and provides support for several
protocols (Database, File, HTTP, MLLP) and for-
mats (HL7 v2/v3, XML, X12, DICOM). The fil-
tering is done through either static rules or E4X
scripts (XML-support for e.g. JavaScript). Trans-
formations are applied on the message level using
XSLT templates, static mappings, or JavaScript.
Finally the outbound data is forwarded to its tar-
get system through one or more destination con-
nectors.
Coupling MC and GOLEM in COMMODITY12
allow us to interoperate the GOLEM agent tech-
nology with a large set of medical devices and sys-
tems. In this way we can deploy personal agents
in the PHS to provide the required high-level and
logic-based functionality for monitoring, alerts,
advice and diagnoses.
3. The LAMA Agent Architecture
This section introduces the LAMA model of
agency, a computational logic architecture that
integrates reactivity and goal-driven planning in
the environment in which the agent is situated.
LAMA is a cut-down version and, in some cases,
an extension of the KGP (Knowledge, Goals,
Plans) agent model [28] with specific focus on
the medical domain. KGP allows the independent
specifications of a collection of computational logic
capabilities especially suited for agents situated in
open and dynamic environments, where the knowl-
edge about the environment is usually incomplete.
3.1. Overview
Fig. 4 demonstrates the LAMA agent architec-
ture. As in [56,13], the agent is composed of two
main software components, a body and a mind.
The body is responsible for physical capabilities
Symptoms 
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Fig. 4. LAMA agent architecture.
like sensing and actuation, thus situating the agent
in an environment. The mind, on the other hand,
allows the agent to symbolically process informa-
tion coming from sensors using the reasoning ca-
pabilities of the agent. During the execution of the
agent, the body perceives the agent’s environment,
and if it senses a change, it will ask the mind to
revise its current action to reflect the perceived
environment changes. The mind also controls the
agent’s knowledge base, which contains medical
knowledge about the domain.
First, we look at how knowledge is represented
in LAMA. We differentiate between online and
oﬄine knowledge.
– Online knowledge represents dynamic data
that is updated through continuous percep-
tion of the agent. These can come in as data
entered from a user interface of the system
(e.g., the physician recording observations of
the patient) or imported automatically (e.g.
laboratory results).
– Oﬄine knowledge represents the profile data
for the patient and disease-related facts and
rules, which will be updated occasionally.
These include static facts related to patient’s
profile (e.g., patient’s birth date), the medical
expertise and guidelines that are required to
draw conclusions for given situations.
Next, we review the physical capabilities of
LAMA.
– Sensing is a physical capability of the body
that allows the agent to observe that proper-
ties hold or do not hold, and that events have
occurred in the environment.
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– Actuation is another physical capability that
allows the agent to act on its environment
through both physical and communicative ac-
tions.
Furthermore, we review the following reasoning
capabilities of LAMA.
– Temporal reasoning is the capability that al-
lows the agent to reason with temporal infor-
mation. It is invoked by other components of
the agent, to prove or disprove that a fluent
literal holds, with respect to a given corpus of
known facts and events.
– Reactivity is the capability that allows the
agent to react to stimuli from the external en-
vironment. When the body of the agent per-
ceives an observation that triggers a reaction,
the mind must respond immediately, possi-
bly by suspending current goals and activities
that can wait.
– Goal manipulation is the capability that al-
lows the agent to decide, at a given time point,
which goals are to be pursued, and which
goals are obsolete. For the ones that are still
pursued, the agent will then select actions
aiming to achieve them.
– Planning is the capability of finding a se-
quence of sub-goals and actions in order to
achieve a goal. Here, we assume that all goals
are already planned for, and the agent uses a
predefined plan library.
3.2. Reasoning
The idea behind the reasoning capabilities of
LAMA is to create a practical reasoning frame-
work that is rich enough to express knowledge rep-
resenting guidelines and medical expertise, use this
knowledge to diagnose conditions, monitor plans
and take action to provide advice and alerts to pa-
tients and medical personnel. We have chosen Pro-
log to be the basis of agent reasoning, because of
its unification capability, proof-oriented computa-
tion, suitability for meta-level reasoning and wide
availability of tools. Prolog, for instance, makes
it possible to compute justifications of generated
advice, which is important if such advice is to be
accepted by medical practitioners. Here, a meta-
logic approach [32] is used to incorporate the rep-
resentation power of extended logic programs in
the framework7.
The framework is based on a hierarchical organ-
isation of conclusions. The most basic level of con-
clusions in the framework are the ones that hold
because the agent has perceived them via sensing
the environment. More specifically, we treat the
observations and actions executed by the agent
as events that happen in time, using the tempo-
ral reasoning capability. As in the original KGP
model, a meta-logic approach allows us to refer
to object-level concepts such as the state of the
agent, fluents representing properties in the state
of the agent that change over time and events that
happen at a time. The underlying time model that
we assume is linear and may include real numbers
or integers. Temporal intervals will be represented
as pairs of time-points.
 
holds_at(P, T):-
T=0,
initially(P).
holds_at(P, T):-
greater_than(T, 0),
holds_for(P, [Start , End]),
greater_than(T, Start),
less_than(T, End).
holds_for(P, [Start , End]):-
initiates_at(Ei, P, Start),
terminates_at(Et, P, End),
greater_than(End , Start),
\+ broken_during(P, [Start , End ]).
holds_for(P, [Start , infPlus ]):-
initiates_at(Ei, P, Start),
\+ broken_during(P, [Start , infPlus ]).
holds_for(P, [infMinus , End]):-
terminates_at(Et, P, End),
\+ broken_during(P, [infMinus , End]).
broken_during(P, [Start , End]):-
(
terminates_at(E, P, T);
initiates_at(E, P, T)
),
less_than(Start , T),
greater_than(End , T).
terminates_at(E, F = V, T):-
initiates_at(E, F = Vnew , T),
holds_at(F = V, T),
V \= Vnew. 
Listing 1: Domain-independent axioms of Event
Calculus.
7Throughout this section we assume familiarity with
logic programming and Prolog.
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We use the Event Calculus (EC) to develop the
temporal reasoning capability of LAMA agents.
The EC is a logic programming formalism for rea-
soning about actions and their effects [33,54]. The
dialect of the EC adopted here assumes multival-
ued fluents, where a fluent is represented in the
form F = V to denote F has value V [7]. In this
dialect boolean fluents are a special case in which
the possible values are true and false. For the
top-level specification of the EC implementation,
we use an efficient version with maximal validity
intervals and multi-valued fluents. The domain-
independent axioms are given in Listing 1.
We give next an example of temporal reasoning
that relates to diabetes: 
initially(calves_pain(right)=false ).
initially(calves_pain(left)=false).
happens(complains_of(calves_pain , right), 1).
initiates_at(
complains_of(calves_pain , S),
calves_pain(S)=true ,
T):-
happens_at(complains_of(calves_pain , S), T). 
Listing 2: Agent’s knowledge about the patient.
This domain-specific information states that ini-
tially the agent believes that a patient does not
have pain in either of his calves. However, after
observation at time point 1 the patient complaint
about pain in the right calf muscle, the observa-
tion is asserted as an event that happens. Then
an initiates/3 rule states that the fluent corre-
sponding to the agent’s belief that the patient has
pain on calf muscle side S is initiated, if a calf pain
event for foot side S has happened. The query
holds at(calves pain(right)=true,1)
is answered by the agent through the use of
the domain-independent EC axioms together with
domain-specific knowledge, and will reply nega-
tively because calves pain(right)=true has not
yet been initiated at T = 1. However, if we ask the
same query at time 2, then the agent will reply af-
firmatively, since 2 is a time after the observation
that the patient complained about pain in her calf.
At the next level of the reasoning framework we
can support deduction with complete knowledge
by describing how the agent can draw necessary
conclusions using domain rules whose conditions
are completely provable (in the classical sense) at
that point within the knowledge base of the agent.
Conditions in the body of such rules can be:
– explicit prior knowledge that holds at all
times, e.g., profile information such as the eth-
nicity of a patient, the fact that a patient is
diabetic, or the target range/type of a value;
– fluents whose values hold at a particular time
because the agent observed events that initi-
ated or terminated them, e.g., that a patient
suffers from calves pain on the right, or that
she has been prescribed a particular kind of
medication;
– new necessary fluents derived as a result of
other necessary conclusions.
As an example of necessary conclusions and
their supporting knowledge is given below: 
necessary_at(diabetic(Patient )=true , T):-
necessary_at(diabetic(Patient , Type)=true , T),
member(Type , [type1 , type2 ]).
necessary_at(P=V, T):-
holds_at(P=V, T).
happens_at(diagnosis(p145 , diabetic(type2)), 2).
initiates_at(
diagnosis(Patient , diabetic(Type)),
diabetic(Patient , Type)=true ,
T):-
happens_at(diagnosis(Patient ,diabetic(Type)), T). 
Listing 3: Drawing necessary conclusions.
The first rule expresses the fact that a patient is
diabetic if the patient has been diagnosed with
type 1 or 2 diabetes. To prove that a patient (say
patient p145) has been diagnosed diabetic (say of
type1) at a specific time (say at time 3), can be
done via the second rule that calls the temporal
reasoning via the EC holds at/2 that uses the
event information and the properties it initiates.
In this way the agent uses necessary rules for flu-
ents sensed in the environment to draw conclusions
about the patient.
In many situations an agent may have incom-
plete knowledge about the conditions that will
make the agent establish that a conclusion G as
true (or false) at a time T. This problem often
arises because the agent is either unable to observe
the truth value of the conditions in the environ-
ment, or because it lacks rules that derive these
conditions from the current state of its knowledge
base. To deal with this, we allow agents to draw
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possible conclusions about conditions that are un-
known to them, as if these conclusions were hy-
pothesised.
As an example of possible conclusions, consider
the following rules:
 
possible_at(feet_Simms_class (3)=true , T):-
possible_at(amputated(F)=true , T),
foot(F).
possible_at(feet_Simms_class (3)=true , T):-
possible_at(ulcer(F)=true , T),
foot(F).
foot(left_foot ).
foot(right_foot ). 
Listing 4: Drawing possible conclusions.
The rules above follow the Simm’s classification
guidelines for determining the foot risk category
for diabetics (see Section 5.2), which state that a
patient belongs to risk class 3 if he/she has an am-
putated foot or has an ulcer on one of the feet.
Typically, this classification is used deductively, to
conclude a certain risk class based on known facts.
If certain fluents are unknown, however, reason-
ing with possible conclusions hypothesises specific
values to boolean fluents, thus helping doctors to
decide which additional observations to make for
a specific case. As with [27], our reasoning process
keeps track of the set of hypotheses that have been
made to prove a conclusion. A fluent is hypothe-
sised if it is undefined in the current state of the
agent and its hypothesis is consistent with the hy-
potheses made so far, as if they are satisfying the
domain-specific integrity constraints.
In order to deal with the problem of integrity in
necessary and possible conclusions, we need to fil-
ter out boolean fluents that are true and false at
the same time. To address this problem we define
legal conclusions that can be thought of as specify-
ing an integrity checking process in the knowledge
base of the agent for necessary and possible con-
clusions. Below we give an example of how these
constraints are defined for necessary conclusions:
 
necessarily_at(P=V, T):-
necessary_at(P=V, T),
legal_at(necessarily(P=V), T).
legal_at(necessarily(P=V), T):-
\+ boolean(V),
in_range(P=V, T).
legal_at(necessarily(P=V), T):-
boolean(V),
opposite(V, OppV),
\+ necessary_at(P=OppV , T).
boolean(true). opposite(true , false ).
boolean(false ). opposite(false , true). 
Listing 5: Necessary conclusions that are legal.
The first rule defines necessary conclusions that
are legal. The second rule states that, for non-
boolean fluents, a necessary conclusion is legal if
the value of the fluent is in the expected range,
a condition that is application defined. Then the
third rule checks that, for boolean fluents, the ex-
plicit opposite value is not necessary at the same
time, thus eliminating any inconsistencies. We can
define possible conclusions similarly: 
possibly_at(P=V, T):-
possible_at(P=V, T),
legal_at(possibly(P=V), T).
legal_at(possibly(P=V), T):-
\+ boolean(V),
in_range(P=V, T).
legal_at(possibly(P=V), T):-
boolean(V),
opposite(V, OppV),
\+ possible_at(P=OppV , T).
possible_at(P=V, T):- necessarily_at(P=V, T). 
Listing 6: Possible conclusions that are legal.
The first rule now defines possible conclusions that
are legal, while the second and third rules deal
with the range of values and inconsistencies in pos-
sible conclusions. The final rule shows how legally
necessary conclusions persist at the possible con-
clusions level, thus establishing the missing link
between necessary and possible conclusions.
Although legal conclusions allow us to use hy-
pothetical reasoning whose conclusions are consis-
tent, it does not allow us to express preferences
over legally possible conclusions. For example, in
the diabetic foot domain, when there is loss of pro-
tective sensibility in one foot then the patient may
belong to class 2 if that patient has in addition an
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arterial condition. However, if the patient has loss
of protective sensibility only, then she belongs to
class 1. So if the patient belongs to class 2 following
the guidelines, then the patient belongs to class 1
too. In this case, the guidelines suggest, that ad-
vice should be provided by taking the higher class
into account.
In practice, the problem described above is often
solved in Prolog systems using the cut (!) operator.
However, this operator makes the rules not declar-
ative. To avoid introducing cut into the rules of
our framework, we define choices over derived flu-
ents with similar legal conclusions. These choices
are further defined in terms of priorities that allow
us to choose the conclusion with higher priority.
Then we extend legally possible conclusions with
what we call valid conclusions as follows: 
valid_at(P=V, T):-
possibly_at(P=V, T),
\+ invalid_at(P=V, T).
invalid_at(P=true , T):-
is_type(choice , P),
higher_priority(Q, P),
possibly_at(Q=true , T). 
Listing 7: Drawing valid conclusions.
Legally possible conclusions that are invalid are
filtered out via the first rule. For choices, a fluent
that is possibly true is invalid if there is higher
priority conclusion that is also possibly true at the
same time. In this way, we can avoid using non-
logical primitives in our rules, and thus having a
reasoning framework that is expressive, declara-
tive and extensible.
3.3. Control
We can now build the agent that uses rules of
the kind described above to provide advice. The
control component of the agent to realise this pur-
pose is provided by a reasoning cycle [26] that is
executed every time the body performs a percep-
tion on the environment and calls the mind. The
body calls the mind with the query:
?- cycle_step(State, Action, NewState).
State is a term of the form:
(Time, Observations, Goals)
BODY
observations
execute action
MIND
cycle
step
call
return
KB
revise
state
select
plan
activate
goal
choose
action
try
action
Fig. 5. LAMA agent cycle.
containing the Observations and Goals of the
agent at the current Time. It is provided as in-
put to the agent cycle that in one step produces
an Action to be performed by the body and a
NewState. In a single cycle step, the mind per-
forms the following tasks:
1. Revises the internal state according to the
new observations coming from the body,
2. Selects a plan for the revised state, creating
new goals.
3. Activates a goal from the set of new goals.
4. Chooses an action in order to achieve the ac-
tivated goal.
5. Tries the selected action (if the action has a
mental part like adding a sub-goal), and re-
turns it to the body together with the newly
formed state of the agent.
This agent cycle is summarised in Fig. 5, and it
can be described in Prolog as follows: 
cycle_step(State , Action , NewState):-
revise(State , RevisedState),
plan(RevisedState , NewGoals),
activate(NewGoals , Goal),
choose(RevisedState , Goal , Action),
try(RevisedState , Goal , Action , NewState ). 
Listing 8: The agent cycle in Prolog.
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After the cycle is completed, the body executes the
chosen action in the environment, e.g., give advice
to the doctor. This action is selected as part of a
plan that is aimed towards the achievement of a
specific goal. We distinguish between two types of
goals, achievement and maintenance goals [65,25].
An achievement goal corresponds to a condition
that the agent needs to satisfy once within a given
period of time, e.g., scheduling of the next foot
examination of the patient. A maintenance goal,
on the other hand, corresponds to maintaining a
condition for a period of time. For example, if the
agent’s goal is to monitor the patient and make
sure his blood sugar does not drop to a critical
level, then it will succeed in that goal if the level of
the patient’s blood sugar stays within the normal
limits for the monitoring period.
4. GOLEM and Mediator Functions
In our PHS, sensor devices stream off physio-
logical values to a centralized care management
system (CMS). The mediator translates these val-
ues in the right formats for all the components in-
volved. Once, the smart hub submits to the medi-
ator the physiological data of the patient, we use
Javascript on the MC side to translate the mes-
sages exchanged in the platform into HL7. Exam-
ple messages that the smart hub sends include the
following observations: (i) glucose, (ii) blood pres-
sure, (iii) weight, and (iv) pulse.
Fig. 1 shows the data flows taking place in the
PHS. All the information produced by the BAN is
translated to an HL7 CDA document to be stored
in the CMS. Furthermore, the stream of data is
also translated to logical terms of GOLEM. Ev-
ery time the smart hub connects to MC to send
the physiological values, MC translates those into
EC events that LAMA agents can interpret. Such
events are then submitted to GOLEM which noti-
fies the agent subscribed to the events associated
to a certain patient identifier, see Listing 9, line 1,
for an example.
In this sense, every agent has a set of sensors
to perceive such events and GOLEM notifies the
agents that are subscribed to the events produced
regarding a certain patient. Namely, we can spec-
ify the subscription of an agent sensor to glu-
cose events as given in Listing 9, lines 2-3. This
means that an agent owns sensor s1 that listens to
blood pressure events of patient p1. Similarly, we
can specify a sensor that listens to glucose events
as given in Listing 9, lines 4-5.
 
1 happens(glucose(p1, 5.5, breakfast , 197), 200).
2 happens(sensor(s1 , blood_pressure(
3 p1, Systolic , Diastolic , Time), 200)).
4 happens(sensor(s2 , glucose(
5 p1, Glycemia , Period , Time)), 201).
6 happens(retrieve_examinations(ag1 , p1), 200).
7 happens(retrieve_lab_tests(ag1 , p1), 200). 
Listing 9: Events in GOLEM.
Below we show part of a sample HL7 CDA docu-
ment body for our PHS, to handle the blood pres-
sure and glucose observations when they are sub-
mitted by MC to the care management system. An
HL7 document is composed of a header, a body
and a footer. Here, we will only discuss the content
of the body, as this is the part where we specify
our observations.
 
<observation classCode="OBS" moodCode="EVN">
<templateId root="2.16.840.1.113883.10.20.1.31"/>
<id root="107c2dc0 -67a5 -11db -bd13 -0800200 c9a66"/>
<code code="271649006"
codeSystem="2.16.840.1.113883.6.96"
displayName="Systolic blood pressure"/>
<statusCode code="completed"/>
<effectiveTime value="200003231430"/>
<value xsi:type="PQ" value="132" unit="mmHg"/>
<interpretationCode code="N"
codeSystem="2.16.840.1.113883.5.83"/>
<referenceRange >
<observationRange >
<text>N 100 -135 mmHg</text>
</observationRange >
</referenceRange >
</observation > 
Listing 10: CDA HL7 message for blood pres-
sure.
An observation OBS is a subclass of an act of
type event EVN. An act is any kind of medical
act during the check-up in the visit to the doc-
tor. The template ID 2.16.840.1.113883.10.20.1.31
is a pointer to the template describing the con-
tent of the observation. The id root 107c2dc0-
67a5-11db-bd13-0800200c9a66 identifies uniquely
the observation. The message contains a single
observation “Systolic blood pressure”, SNOMED
code 271649006, with numeric value 132 mmHg.
The code system id 2.16.840.1.113883.6.96 iden-
tifies the SNOMED CT code system. The effec-
tive time is the time stamp of the event, while PQ
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 
1 possible_at(select(monitor_hypoglycemia , alert([ doctor], severe_hypoglycemia ))=true , T):-
2 lastday(Ts, T),
3 findall(Val , (holds_for(glucose=value(Val), [Ts, T]), severe_hypoglycemia(Val)), HypoCases),
4 length(HypoCases , L), L >= 2.
6 severe_hypoglycemia(Value):- Value >= 3, Value =< 4. 
Listing 11: Possibility rule for severe hypoglycemia alert.
stands for Physical Quantity and it refers to the
value and the unit. The interpretation code defines
if the observation is normal, high or low; in this
case normal. The observation range is a text com-
ment specifying the range of the values for being
in normal condition.
In COMMODITY12 agents can also query the
patient’s profile. In particular, the profile con-
tains: (i) physical examinations like the annual
foot examination, the eye check, the check for
neurophatic symptoms, waist circumference, (ii)
lab tests like cholesterol values, the HbA1c value,
blood pressure, serum values, protein in the urine,
and (iii) the patient’s history like family history
and habits, such as smoking and drinking alcohol.
To achieve such a communication between
GOLEM and PHS DB (as depicted in Fig. 1), we
define a set of queries in both GOLEM and in the
DB. In GOLEM, we specified a set of events in
the EC formalism to deal with the notification and
subscription of lab test events and physical exam-
ination events to the LAMA agents. Every time
the agent is deployed in GOLEM to serve its own
patient, the agent requests the changes in the pa-
tient profile, by requiring the most recent physical
examinations and lab tests. To achieve this, after
deployment time, the agent produces the events
given in Listing 9, lines 6-7.
Such events are submitted to MC by GOLEM,
which then submits the query to the DB. The DB
queries the repositories by means of SQL state-
ments. The result of the SQL query is returned
back to MC in HL7 format and translated to pred-
icates. We use a DB schema based on the HL7 V3
RIM model [52,24]. The use of HL7 V3 RIM is
fundamental as this simplifies the creation of mes-
sages that respect the HL7 CDA format.
5. Case Study
5.1. Hypoglycemia Monitoring
Hypoglycemia is the case where the glucose
level of the patient is below a certain thresh-
old value (International Classification of Diseases
(ICD): ICD-10, E16.0-E16.2)8. Continuous moni-
toring of the glucose level for different periods of
time (e.g., before lunch or before dinner) is essen-
tial in detecting an abnormal case for the patient.
According to the severity level of hypoglycemia,
different actions may need to be taken including
alerting the doctor. Here, we focus on one specific
case that is described by the following algorithm:
Monitor
hypoglycemia
3 ≤ Glucose ≤ 4 Alert the doctor
measure glucose level
twice within
the last day
In particular, the rule we are interested in de-
scribes a severe hypoglycemia case, where the pa-
tient has two cases of hypoglycemia within the
last day. In such a case, the action to be taken
is to alert the doctor of this situation. Listing 11
demonstrates how we represent this rule in our
reasoning framework. This rule is stored in the
agent’s knowledge base where it can be accessed
at every cycle of the agent’s execution. The head
of the rule selects a suitable action for the given
situation given that the conditions in the body of
the rule hold. So, for our specific rule, when the
current situation of the agent is to monitor for hy-
poglycemia (line 1), then in order for the rule to
fire, the following needs to hold:
8http://www.who.int/classifications/icd/en
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– The time period to be checked is within one
day (line 2).
– At least two cases of severe hypoglycemia
have occurred within the last day. Using
temporal reasoning, line 3 finds all glucose
measurements from the last day that clas-
sify as severe hypoglycemia. Line 4 expresses
that at least two of such measurements must
be found. Finally, line 6 states that a glu-
cose value is classified as severe hypoglycemia
when it is between 3 and 4 mmol/l.
Note that glucose measurements can be pro-
vided by the patient via the smart hub as well as
by the doctor through the web interface. When the
measured glucose values are at critical levels, the
agent selects the action to alert the doctor (line
1). This alert is then passed to the doctor via the
connection between GOLEM - Mirth Connect and
Mirth Connect - web interface. The recipient of
the alert contained within the action description.
5.2. Foot Ulceration
Foot complications are among the most serious
and costly complications of diabetes, possibly re-
sulting in the amputation of the patient’s lower ex-
tremity. Because of the nature of the diabetic foot9,
a multidisciplinary approach is needed to prevent
ulceration, amputation, decrease in patients’ qual-
ity of life, and high medical costs. Early detection
of the at-risk foot, as well as adequate and timely
treatment, are key aspects of such an approach.
In order to aid medical practitioners, general
guidelines have been developed that allow for clas-
sification of diabetic patients into different risk
categories, based on the condition of their feet [5].
Typically, those guidelines describe basic princi-
ples for prevention and treatment of the diabetic
foot, and need to be translated for local use when
implemented in practice, taking into account re-
gional differences in socio-economics, accessibility
to healthcare, and cultural factors.
In the Netherlands, the Dutch Association of In-
ternists has put forward Guidelines for the Dia-
betic Foot describing four different risk categories
9The term “diabetic foot” here refers to the spectrum of
foot deformations as a result of neuropathy, macroangiopa-
thy, limited joint mobility, and metabolic disorders, which
typically occur in diabetic patients [5,66].
Class Risk profile Frequency
0 No LPS or PAD 1x / 12 mo
1 LPS or PAD, without LIP 1x / 6 mo
2 LPS together with PAD or LIP 1x / 3 mo
3 History of ulcers or amputation 1x / 1–3 mo
Table 2
The modified Simm’s classification.
related to the diabetic foot, each of which has an
associated check-up frequency with which the spe-
cialist is advised to see the patient. These guide-
lines encompass a set of rules known as the “modi-
fied Simm’s classification” [64,55], as shown in Ta-
ble 2.
According to the rules of the modified Simm’s
classification, the patient falls into risk category 2
when she shows loss of protective sensibility (LPS)
in the feet, together with peripheral arterial dis-
ease (PAD) or signs of locally increased pressure
(LIP). The physician is then advised to see the pa-
tient at least once every six months. To determine
if the patient is aﬄicted by any of the factors that
influence the outcome of the Simm’s classification,
the physician performs an anamnesis and inspects
the patient’s feet. The data is then entered into
the PHS, using a form as in Fig. 6 that depicts
part of the entry form for the foot examination.
Whether or not the patient has a history of ulcers
or amputation is observed by the physician during
the examination, or inferred from historical obser-
vations available to the PHS. Other observations
that are related to the presence of items in the
Simm’s risk profile of Table 2, are as follows:
LIP is indicated if the patient has any of:
– tylosis or clavus
– pressure sores
– a skin defect, or signs of infection
LPS is indicated if the patient has any of:
– superficial sensitivity disorder, as measured
using the Semmes-Weinstein monofilament
PAD is indicated if the patient has any of:
– pain in calves while walking
– spasmodic pain in calves while lying down
– difference in temperature between his/her feet
– no pulsation in a single a. tibialis posterior
– no pulsation in a single a. dorsalis pedis
– no pulsation in both a. tibialis posterior, and
no pulsation in both a. dorsalis pedis
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Fig. 6. Foot examination entry form.
The rules of the Simm’s classification are for-
malized in Listing 12. Let us now look at an inter-
esting case when a given observation triggers both
risk categories 1 and 2. The conditions needed to
conclude that a patient belongs to category 1 and
category 2 are given in the listing. Note that the
observation loss of protective sensibility, which
is a neuropathy condition, is included in both
classes. In order to resolve conflicts that may arise
from observations of this type, we use valid con-
clusions as described in Section 3. So, if it is pos-
sible to conclude both category 1 and category 2
out of the observations for the patient, then only
category 2 will be valid since it has higher priority.
For example, a doctor first fills in the observa-
tions about the patient, using the web-based in-
terface (Fig. 6) of the Portavita PHS that is used
as basis for the COMMODITY12 architecture. To
simulate the case described above, the correct pa-
rameters are entered using the form elements of
the interface. Then, based on the rules of the clas-
sification, it is possible to conclude both Class 1
and Class 2. Finally, Class 2 is selected as the final
Simm’s classification category, advising a foot ex-
amination once every three months. The resulting
advice is depicted in Fig. 7.
5.3. PHS User Interface
The treatment of diabetes involves caregivers
from multiple disciplines, such as general prac-
titioners (GPs), dietitians, ophthalmologists, chi-
ropodists, pharmacists, specialists and nurses. The
set of Web services developed in the Portavita10
system helps caregivers managing the care for
chronic diseases such as diabetes. All caregivers
in the treatment of a patient can be authorized
to parts of the patient health record such that
they can give a specific contribution. Moreover,
the patient can be actively involved because she
10http://www.portavita.eu/
Fig. 7. Generated advice for the foot exam.
has access to her health record and can per-
form self-examinations. The Portavita Diabetes
KIS was produced in close cooperation with GPs,
internists, paramedics, nursing staff and the pa-
tients’ association DVN11. It was also based on the
guidelines of the Dutch diabetes foundation12.
After the patient is diagnosed with diabetes,
the treating physician asks for the disease history
of the patient, lifestyle and other general condi-
tions. The patient and the physician together then
use this information to construct an individual
treatment plan. The treatment plan contains tar-
get values concerning body weight, glucose reg-
ulation, blood pressure, lipids and kidney func-
tion. Furthermore, the physician and patient agree
upon the monitoring of the patient’s adaptation
of lifestyle, cardiovascular risk profile, feet, eyes,
and kidney function. If the patient fails to achieve
the agreed upon target values, the physician and
patient will decide upon changing the therapy.
Typically it takes about 3 months to obtain a
stable configuration of target values and moni-
toring. When a stable configuration has been ob-
tained, the physician will perform a check-up at
least every 3 months in which special attention
is given to complaints, problems with adaptation
of lifestyle, body weight, glucose regulation and
blood pressure. Once a year a more thorough
check-up is performed in which all aspects of dia-
betes and its treatment are evaluated.
To ensure that certain steps are taken, care-
givers must follow a particular workflow when per-
forming an examination. Starting a new exami-
nation triggers a new workflow that enforces that
11http://www.dvn.nl
12http://www.diabetesfederatie.nl/
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 
possible_at(select(classify_feet , recommend(feet_check_up(Frequency )))=true , T):-
possible_at(diagnosed(diabetic )=true , T),
possible_at(feet_check_up('Simms ', Frequency )=true , T).
% Class 3
possible_at(diabetic_feet_Simms_class (3)=true , T):-
possible_at(amputated(F)=true , T),
foot(F).
possible_at(diabetic_feet_Simms_class (3)=true , T):-
possible_at(ulcer(F)=true , T),
foot(F).
% Class 2
possible_at(diabetic_feet_Simms_class (2)=true , T):-
possible_at(neuropathy_condition(loss_of_protective_sensibility )=true , T),
(
possible_at(arterial_condition(peripheral_arterial_disease )=true , T);
possible_at(signs_in_feet(locally_increased_pressure )=true , T)
).
% Class 1
possible_at(diabetic_feet_Simms_class (1)=true , T):-
possible_at(neuropathy_condition(loss_of_protective_sensibility )=true , T).
possible_at(diabetic_feet_Simms_class (1)=true , T):-
possible_at(arterial_condition(peripheral_arterial_disease )=true , T).
% Class 0
possible_at(diabetic_feet_Simms_class (0)=true , T):-
\+ possible_at(diabetic_feet_Simms_class (3)=true , T),
\+ possible_at(diabetic_feet_Simms_class (2)=true , T),
\+ possible_at(diabetic_feet_Simms_class (1)=true , T).
% Priorities between conclusions
higher_priority(diabetic_feet_Simms_class(X), diabetic_feet_Simms_class(Y)):-
more_severe(X, Y).
% Higher classes
more_severe(X, Y) :- X > Y. 
Listing 12: Formulation of diabetic foot based on the Simm’s classification.
several steps are taken. When entering a new ex-
amination, the user (e.g., healthcare personnel) is
required to enter certain data in the examination
form. What is required depends on the examina-
tion and the entered values. For example, if the
user enters that the patient smokes, then he must
also enter how much. Fig. 6 shows a part of the
foot examination, where the outcomes of several
tests can be entered. On the right, previous ob-
servation values are showed to clarify whether a
condition has changed.
When the user is done entering observations, the
examination must be accorded before it is stored
in the patient’s health record. However, exami-
nations can also be submitted without being ac-
corded. In this case, the examination still has to be
accorded before it is stored. For example, an assis-
tant could enter the examination, but the treating
physician has to accord it before it is stored in the
patient’s health record. During the process of en-
tering an examination the user can pause the ex-
amination. The examination then appears on the
worklist of the user. Additionally, there is function-
ality to plan examinations and to request an ex-
amination at another organization or a colleague.
After an examination is saved, it is available
to all other users that are involved in the pa-
tient’s treatment. Various examinations are sup-
ported that are particularly relevant to diabetes
such as risk inventory, annual check-up, routine
check-up, foot examination, interim check-up, self-
check, laboratory test, dietary advice, and fundus
image screening.
The physician can also register what medica-
tion a patient takes. The Anatomical Therapeu-
tic Chemical (ATC) Classification System is used
to denote what medication is administered. The
ATC is a pharmaceutical coding system that de-
scribes drugs by their therapeutic and chemical
characteristics. It is controlled by the WHO and
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Fig. 8. The monitor gives an overview of the patient’s condition.
was first published in 1976. The user has to select
what drug, how many doses per day, the quantity
per dose (e.g. how many pills), and the start and
end date of the medication.
Because different caregivers can enter new in-
formation about a patient, it is important to be
able to get an up-to-date overview of the patient’s
condition. The monitor is the part of the applica-
tion that shows the information of a patient that
is most relevant to his treatment as can be seen
in Fig. 8. There is a section with the diagnosis
and risk factors of the patient and another named
outcomes and process that summarizes the most
important measurements and whether certain ex-
aminations have been performed. In the memo
section, caregivers can enter messages to each
other. The treatment policy section provides the
dates and remarks of the most important exami-
nations that were performed. The medication sec-
tion shows the medication that the patient takes
and finally, the treatment team sections shows the
caregivers relevant to the patient’s treatment. A
special part of the monitor is the decision support
tab (see Fig. 9) in which the user is presented the
alerts generated by the COMMODITY12 system.
Fig. 9. Alerts concerning the treatment.
6. Related Work
In this section, we review the literature on med-
ical sensors, diabetes management, (agent-based)
automated diagnosis and other interoperability so-
lutions for e-health.
6.1. Medical Sensors
Multi-parametric approach to Diabetes monitor-
ing: This research takes into account the need ex-
pressed by medical professionals to monitor more
than one single parameter in order to be able to
better judge the evolution of diabetes 1 or 2 pa-
tients. To guarantee sensor reliability and data
quality the use of reliable sensors was prioritised
due to the need to secure the clinical trial and
patient monitoring success. Within the aforemen-
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tioned remit this section highlights the most rele-
vant related work to the sensors and wireless con-
nectivity of this project.
Available wireless platforms: Modular wireless
sensor platforms represent great potential for lab-
oratory research. The most relevant in this cate-
gory is the Shimmer platform [17]. Unfortunately
Shimmer modules are too large for practical use
in a clinical trial, this being caused principally by
the choice of relatively high power consumption
Bluetooth and ZigBee wireless protocols requiring
larger batteries than desired. Accelerometers have
been proven to be reliable sources of information
for activity monitoring [39] while other approaches
involving surface electromyography to detect mus-
cle fatigue have been presented in literature [1] yet
the use of electrodes still represents a hurdle for
user acceptance. Further commercial products for
physiological monitoring exist such as the Zephyr
BioHarness 3 13 and the Equivital EQ02 Life Mon-
itor 14. These devices use Bluetooth and hence are
limited in the duration that they can monitor wire-
lessly in a continuous fashion. Nevertheless they
are worthy of mention as smart duty cycling of
such transmission would result in power savings.
Finally, given the need to provide monitoring
for long periods of time lower power consumption
wireless network protocols were preferred as a first
approach over options such as the Shimmer system
or others relying on Bluetooth.
Continuous glucose monitors: The field of Con-
tinuous Glucose Monitors has received a large
amount of attention and focus from medical de-
vice companies and several wireless products have
recently been announced such as the Dexcom G4
Platinum monitor15. This monitor has wireless ca-
pabilities but only transmits to a dedicated pocket
base station. Dexcom is currently working on the
new G5 model that is described as being able to
connect to an Android smart phone in a wireless
fashion. Because the G5 product has not reached
the market yet it could not be included in the pre-
sented research at this point in time but will be
followed closely for potential interoperability with
the smart hub. Further CGMs with wireless ca-
13http://www.zephyr-technology.com/products/
bioharness-3/
14http://www.equivital.co.uk/products/tnr
15http://www.dexcom.com
pabilities such as the Abbott Freestyle Navigator
II 16 present a step forward in wireless continu-
ous glucose monitoring for users but are still lim-
ited for interoperability with other systems given
their reliance on proprietary data communication
schemes. Considering that the pocket base station
of the G4 model did not provide a significant ben-
efit over other non-wireless CGMs and that the
Medtronic CGM is already available at the DM1
clinic of this project the later sensor was preferred.
6.2. Healthcare Management Systems
The user experience of e-health environments
for diabetes has been addressed before [40]. The
authors investigate diabetes self-management prac-
tices and possible impact factors on future lifestyle
choices via a set of experiments. As a result, they
discuss opportunities and outline possible direc-
tions for the design of e-health applications for
diabetes. They argue that pervasive computing,
sensor networks and monitoring devices can be
combined with machine learning techniques for
individuals to keep track of their actions in an
unobtrusive way and to provide ground for in-
formed decisions. Furthermore, the authors pro-
pose a decision cycle within the diabetes man-
agement which can be employed in e-health sys-
tems: (i) keep track of performed actions, (ii) mon-
itor blood sugar level, (iii) identify any changes
in blood sugar, (iv) attribute the change to par-
ticular actions, and (v) modify behaviour based
on learned inferences. This work is fundamental
for COMMODITY12 since on one hand it stresses
a patient-centric design, and on the other hand,
it provides empirical justification for the develop-
ment and the deployment of the smart e-health
environment presented in this paper.
In [11], the authors provide a conceptual frame-
work for a communication software architecture to
realise mobile-device computing and sensor inte-
gration. Here, the main objective is to create a
transparent and timely communication model that
allows different mobile devices to perform different
tasks such as patient monitoring and intervention
in the health-care process. The model presented
integrates its own tailored ontologies for knowl-
16https://www.abbott-diabetes-care.de/de-de/
produkte/kontinuierliches-glukose-messsystem/
freestyle-navigator-ii/
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edge generation and pattern-based software engi-
neering. Similar to the COMMODITY12 e-health
environment, its architecture is layered. The lay-
ering is based on a semantic overlay network im-
plemented as a distributed application by means
of an object oriented middle-ware for distributed
systems. This allows a wide variety of devices to
be connected. In contrast to COMMODITY12, the
authors emphasise the theoretical part of such an
ambient intelligence environment: details about
the sensors, data-processing and end-user evalua-
tion are omitted.
The SINDI system [41] deploys a logic-based
model to reason about different pieces of knowl-
edge for context-aware situation assessment. The
focus is on health-care in an assisted-living context
for people without a chronic disease. Although
the domain is different from COMMODITY12, the
functional purposes of the two systems are sim-
ilar: different data sources need to be gathered,
integrated and processed by a reasoning engine.
Combining these data with a model of medical
knowledge, SINDI identifies and prevents risks via
declarative feedback policies. In their approach,
Answer Set Programming is used instead of the
meta-logic framework presented here. Another re-
lated application that focuses on the domain of
assisted living is presented in [60]. The authors
propose an approach for structuring knowledge
and reasoning for high-level interpretation of sen-
sor data. They follow a knowledge-based approach
that includes rules and ontologies. Instead of using
EC for temporal reasoning, they rely on a simpli-
fied generalisation of events. Their work bridges
the gap between this high-level reasoning and raw
sensor data with an abstraction layer that employs
numerical reasoning for symbolic conclusions. In
contrast to COMMODITY12, they employ very
basic sensors such as thermometers and sensors
that check whether doors are open or closed.
Another important area of research in diabetes
management is activity recognition [47]. Here, the
authors present a prototypical application, broad
to the context of mobile and pervasive computing,
where a Hidden Markov Model is fitted to a user’s
location and activities. Given this model, the au-
thors try to predict the state of activity and the
user’s location. By using heuristics and tuning pa-
rameters of the model, the authors try to enrich
the model with the context of a specific user and a
specific situation, e.g., going to work or exercising.
The long-term objective of this study is to improve
support for online learning and context-awareness
of individual users and to predict future activities
to prevent blood glucose level swings. The work
differs from ours in two major points: first, we fol-
low a more top-down approach. We try to start
from the medical point of view in terms of treat-
ment and enhance these viewpoints with technical
solutions. Second, we employ a more sophisticated
sensor system.
6.3. Medical Diagnosis and Agents
From a technical point of view, diagnosis is de-
fined as the process of interpreting the observa-
tions that are received from a system domain, and
identifying whether there are any faults associated
with the system by comparing the expected be-
haviour of the system with what has been observed
[38]. Diagnostic problem solving can be applied to
a variety of domains like electronics [57], medical
systems [23], and software debugging [6].
Similarly, medical diagnosis is the process of
identifying a disease based on the symptoms that
are observed on a patient [36]. There are differ-
ent approaches to medical diagnosis. In fault-based
(heuristic) approaches, the idea is to encode the
diagnostic reasoning of human experts in a given
domain. The real-world system is not modelled.
All known faults are modelled instead. Conversely,
model-based diagnosis (MBD) starts from a model
of the structure (components and their connec-
tions), and a set of observations indicating a nor-
mal behaviour. A system is then considered faulty
if the observed behaviour of the system contradicts
the expected (normal) behaviour.
The model-based approach to diagnosis has
been started out to identify faults in electronic
circuits, for which considerable amount of work
has been performed by de Kleer [19]. The idea
is to describe the system with a model, and pro-
vide a function that accounts for the normal be-
haviour [38]. This formal theory of diagnosis is
called consistency-based diagnosis by Reiter [48].
Consistency-based diagnosis models the normal
(expected) behaviour of the system using a logic
framework, and it identifies faults through discrep-
ancies between the predicted normal behaviour
and the observed abnormal behaviour.
Another computational method to employ di-
agnosis is to use abduction, in which a model of
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the abnormal behaviour is used in terms of cause-
effect relations [46,18]. In the idea of abduction,
reasoning flows from effects to causes. In a deduc-
tive logic program with the rule P → Q, one can
conclude Q whenever the condition P is in the
knowledge base. In abduction, however, the aim
is to assume that the condition P must be in the
knowledge base whenever one observes Q in the
environment, giving the rule a semantics of “P has
caused Q”.
Another alternative for performing model-based
diagnosis in the medical domain is to combine the
ideas used in deduction and abduction. In a gen-
eral sense, the medical guidelines are represented
by forward rules from symptoms to diseases. If
all the necessary symptoms are indeed observed
on the patient, then the corresponding disease is
drawn as a conclusion, as in classical deduction.
However, if some of the symptoms are observed
and others are not, the remaining symptoms are
assumed to hold, as in abduction. This set of as-
sumed symptoms are then given as advice to the
doctor, so that they can be concluded via further
relevant tests in order to classify the symptoms
into a disease. Enumerating defects and describ-
ing these defects via a set of observable findings
corresponds to what Lucas calls an abnormality
classification diagnosis [37].
In recent years, the model-based diagnosis ap-
proach has been applied to multi-agent systems
diagnosis [18], with applications in the automotive
industry [45], plan diagnosis [50], and coordination
failures in agent teams [29,30]. These are in gen-
eral closed systems, where the agents or compo-
nents included in the system are fixed during ex-
ecution. Agent-based approaches are not new for
the medical domain. They are used in the litera-
ture to manage community health care [9], retrieve
medical knowledge [8], decision support systems
for monitoring and diagnosing diseases [35], dis-
tributed patient scheduling within a hospital [20]
and improving the coordination between hospitals
for efficient management of organ transplants [3].
There are also agent-based frameworks developed
solely for the purpose of improving health care,
some of which are ASPIC [22], SAPHIRE [34],
K4CARE17.
17http://www.k4care.net
6.4. Interoperability Solutions
The epSOS project18 aims at creating an inte-
gration broker for cross border exchange of pa-
tient’s health records. In epSOS there is no mech-
anism defined to handle the subscription of new
communities, thereby the responsibility to connect
different healthcare providers falls into the epSOS
operator. In our framework, the use of Mirth Con-
nect solution can be seen as the epSOS broker,
with the difference that Mirth Connect can define
channels to connect the various entities in the sys-
tem and it works as an interoperability mediator.
The MediCoordination Healthcare Infrastruc-
ture (MHI) [4] aims at improving the accessing
and sharing of important medical data between
medical actors. MHI’s architecture consists of a
registry and two clients, one for submitting docu-
ments and one for receiving them. An XDS-based
server is used for the repository and the registry.
The IHE XDS Integration Profile describes an
infrastructure based on standards (ebXML), for
managing the information exchange of sensitive
medical data. The MHI prototype does not imple-
ment notifications [4]. General practitioners have
to manually query the registry and client-server
communications are channelled through a SOA-
based service. With respect to MHI, our infras-
tructure hides to the actors the complexity of us-
ing the infrastructure by defining a publish and
subscribe mechanism between the involved compo-
nents (Smart Hub, GOLEM, Mirth Connect, Web
Services).
As reported in [21], ARTEMIS is a project that
provides interoperability for healthcare by seman-
tically enriching Web services. Such semantically
enriched web services are then connected by means
of the JXTA P2P infrastructure. A JXTA su-
per peer represents a community where different
health actors can interact. The ontologies in the
medical domain are mapped directly to different
ontologies related to the heterogeneous IT sys-
tems making use of ARTEMIS. A set of media-
tor components is then used to consent heteroge-
neous services to communicate. With respect to
ARTEMIS, we do not make use of semantic repre-
sentations, as our complex event processing com-
ponents rather focuses on detecting patterns in
18http://www.epsos.eu
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the physiological events produced by the patient.
Furthermore, the problem of representing health
concepts is already addressed by standards like
SNOMED CT19, which within COMMODITY12
are used in CCD messages that are then inter-
preted by the web services.
With respect to ARTEMIS, which only focuses
on the communication amongst the components
in the infrastructure, our agents are dedicated
to perform reasoning on the event patterns as-
sociated with the condition of the patient. As
a matter of fact, in COMMODITY12 we aimed
at creating a platform that could support any
kind of chronic illness, by separating the concerns:
COMMODITY12 implements a distributed event-
based system where the agents are subscribers of
the events produced by the patient. The physio-
logical values of the patient are represented using
standards such as CCD, which allows us to hide
the complexity of interfacing the monitoring sen-
sors with the smart hub solution and to translate
the messages to the language understood at the
agent level (Prolog terms).
The Provenance project [31] defines a multi-
agent system that records the patient’s complete
health care history (located in different communi-
ties). Each community creates and processes the
documentation using p-assertions that are stored
in a Provenance store. The p-assertions are as-
sertions triggered by the documentation of a pa-
tient’s health treatment process and indicate in-
formation such as which is the medical doctor who
generated a record, what were the basis for the
given treatment, and when the record was cre-
ated. Rather than using p-assertion, we use CCD
to represent our messages, with the addition of
SNOMED CT and LOINC codes. Furthermore, we
do not only have doctors producing information
about patients, but also the patients themselves,
by using the smart hub, can produce CCD mes-
sages containing medical information.
Similarly to COMMODITY12, Provenance per-
forms event processing on the events produced
by the patients and the doctors. Differently from
COMMODITY12, Provenance does not define
complex event pattern components, such as our
LAMA agents, to handle complex event patterns
19http://www.nlm.nih.gov/research/umls/Snomed/
snomed_main.html
produced by the patients. Also, the reasoning per-
formed in Provenance focuses on defining trigger-
ing rules on the current health records of the pa-
tient. In COMMODITY12 we consider temporal
patterns both on the long and short term: the de-
cision taken by the agent is associated with the
physical examinations of the patient at the doc-
tor side, on the lab tests evolution, and on the
physiological values collected with the smart hub
component.
Triple space computing (TSC) applied to health-
care [43] uses tuple spaces to foster the exchange
of information and proposes the use of semantic
web technology to represent the data about the
patients. Their solution associates RDF tuples to
concepts defined in HL7 or SNOMED. This so-
lution differs from ours as we are not concerned
with translating HL7 concepts into a semantic
web language. Here, we are interested in defining
complex event processing on the multi-parametric
physiological values of the patient, rather then se-
mantic reasoning amongst concepts expressed in
RDF. From the perspective of the computation,
also TSC considers the problem of publication and
retrieval of health information, but it does not
describe the notification and dispatching of the
events happening in the distributed systems, while
here we use GOLEM and Mirth Connect to handle
the publication and subscription of events.
In particular, our approach has a deeper gran-
ularity than the one proposed in TSC. As a mat-
ter of fact, COMMODITY12 focuses on a multi-
layered approach where our agents represent the
subscribers to the events produced by the patient.
In this way, agents are left with the task of reason-
ing about the data produced by the patient, rather
than having to deal with infrastructure problems
such as in TSC and in other approaches.
In [58], Tentori et al. present a pervasive health-
care infrastructure that takes into consideration
the problem of privacy of the patients. The plat-
form agent presents to patients, when they inter-
act with the platform, several privacy choices when
handling their data. The interaction between the
patient and the intelligent agents is handled by
means of a negotiation protocol. With respect to
[58], COMMODITY12 utilises the Portavita plat-
form to deal with privacy concerns of the user.
Portavita represents the web interface of the pa-
tient. In particular in COMMODITY12 the final
owner of the data is always considered to be the
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patient, who is the only one that decides which
party can have access to the data. In principle, the
patient could use COMMODITY12 as a diabetic
diary without allowing doctors to observe his/her
physiological values.
Finally, in [59], Tentori et al. present an activity
recognition framework based on the SALSA agent
library [49]. The framework proposed in [59] is the
most similar to COMMODITY12 in terms of archi-
tecture as it implements a distributed event-based
system where the agents perform reasoning on
the activity performed by the patients. Differently
from COMMODITY12, the framework presented
in [59] utilizes Hidden Markov Models (HMM) to
classify the activity of the patient. For the mo-
ment, in COMMODITY12 we put most of our ef-
fort on translating guidelines to monitoring rules,
so to be able to apply the guideline on the physi-
ological value of the patient. Machine learning ap-
proaches towards patient diagnosis are currently
planned for the COMMODITY12 project. How-
ever, the focus will be on methods that are logic-
based or that can use data to provide an explana-
tion on the current situation of the user by means
of causality models, such as in [53]. As this is of
increasing importance to medical doctors experts
in diabetes, who need to understand how the re-
lationship amongst the physiological values of the
patient evolves in time so that to apply a better
treatment to patients.
7. Conclusions
We have presented a Personal Health System
(PHS), called COMMODITY12, that assists in the
provision of continuous and personalised health
services to diabetic patients, with the aim of em-
powering their lifestyle regardless of their loca-
tion. COMMODITY12 consists of ambient, wear-
able and portable devices, which acquire, mon-
itor and communicate physiological parameters
and other health-related context of an individual,
such as physical activity and vital body signals.
The data are interpreted by personal agents that
use expert biomedical knowledge to derive impor-
tant insights about the individual’s health status,
which are then presented in the form of active feed-
back to the patient directly from the device, or via
health professionals who assist in diagnosis, treat-
ment and life management.
Our work has focused on the design of the PHS
in terms of its main components, their integration
and deployment to address major problems of in-
terest to both diabetic patients and doctors that
treat diabetes. In this context, our contribution is
as follows.
– We have presented a generic system archi-
tecture for a PHS specialised on continuous
monitoring of diabetes patients. The practical
significance of the architecture is that it in-
tegrates sensors, intelligent agents, databases
and users within a single system. The ap-
proach taken differentiates between domain-
specific and generic requirements for such a
PHS and develops the components of the
framework so that they can be reused in a
different domain by integrating the necessary
sensors and medical knowledge accordingly.
– We have identified a set of commercially avail-
able sensors that aid the monitoring of dia-
betes patients and have discussed how these
sensors can be organised to provide input to
the overall system.
– We have specified a model and architecture,
called LAMA, to develop software agents
that can reason about the medical domain
of diabetes to support patients and medical
personnel. LAMA agents are endowed with
useful reasoning capabilities and a knowledge
representation framework that can support a
range of requirements, from monitoring to di-
agnosis.
– We have discussed how to deploy LAMA
agents through the use of the GOLEM plat-
form, thus allowing the distribution of PHS
components over a complex computer net-
work.
– We have shown how to integrate different
components via a mediator that translates
information between agents, sensors, medical
databases, web services and user interfaces,
thus making the PHS robust and extensible.
– We have grounded the ideas, models, tech-
niques and technologies through the develop-
ment of two case study scenarios on diabetes
management.
– We have compared and evaluated our ap-
proach with relevant work in the literature for
all the components and technologies used in
the proposed PHS.
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As part of our future work we plan to include
the patient’s profile more actively in the treatment
process. The profile of a patient contains clues on
the lifestyle and the surroundings of the patient as
well as her medical history. It is very important
that patients get the suitable treatment plan tai-
lored to their needs and lifestyle. The profile infor-
mation can be used to detect exception cases that
distinguishes a patient from one with a “normal”
profile. One such exception is about the working
hours of a patient. For example, if a patient works
late from midnight to morning, then the doctor
may have to deviate from a normal treatment plan.
Another important future goal is to introduce
uncertainty to the reasoning process of agents by
specifying a data-driven capability that takes ad-
vantage of the data collected live via the BAN and
available in the current system database contain-
ing health-records of 20,000 diabetic patients. We
have already made some progress with analysing
big-data of this kind with a multi-dimensional
causal discovery method that we have introduced
in [53], but additional work is required in this im-
portant area.
We also plan to perform a monitored end-user
evaluation through clinical trials carried out by the
doctors of our consortium. These clinical trials will
be conducted with peer-reviewed protocols that
are approved by ethical committees, thus guaran-
teeing high scientific standards. Here we will ex-
amine a considerable number of patients in two
European countries, divided in treatment and con-
trol groups. For evaluating the system, we pre-
define the following outcome measures. First, we
would like to assess objective improvement of di-
abetes management. This can be measured with
the percentage of complications associated to dia-
betes type 1 and 2 correctly identified by the sys-
tem. Then, we would like to evaluate the num-
ber of complications associated with cardiovascu-
lar co-morbidities that have been correctly identi-
fied by the system. We would also like to see how
the patients respond to the different treatments
and assess if the platform can provide the correct
treatment adjustment.
In the longer term, we want to determine the
effects of the system on the quality of life of par-
ticipants via questionnaires, analyse how patients
deal with the use of sensors and report our find-
ings to the e-health community. We also want to
study the effort of moving our approach from one
domain to the other, from sensors and databases
to programming agents with different domain spe-
cific knowledge.
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